Your search returned 2033 results.

Results
	1841.	Systemic treatment for BRAF-mutant melanoma: where do we go next? [electronic resource] by Menzies, Alexander M Long, Georgina V Producer: 20141215 In: The Lancet. Oncology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1842.	Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme. [electronic resource] by Altomonte, Maresa Di Giacomo, Anna Queirolo, Paola Ascierto, Paolo Spagnolo, Francesco Bajetta, Emilio Calabrò, Luana Danielli, Riccardo de Rosa, Francesco Maur, Michela Chiarion-Sileni, Vanna Ferrucci, Pier Giannarelli, Diana Testori, Alessandro Ridolfi, Ruggero Maio, Michele Producer: 20140926 In: Journal of experimental & clinical cancer research : CR vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1843.	The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus. [electronic resource] by Szucs, Thomas D Puri, Daniele Blank, Patricia R Producer: 20150219 In: European journal of clinical pharmacology vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1844.	Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma. [electronic resource] by Weber, Jeffrey S Kudchadkar, Ragini Reiney Yu, Bin Gallenstein, Donna Horak, Christine E Inzunza, H David Zhao, Xiuhua Martinez, Alberto J Wang, Wenshi Gibney, Geoffrey Kroeger, Jodi Eysmans, Cabell Sarnaik, Amod A Chen, Y Ann Producer: 20140123 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1845.	The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma. [electronic resource] by Scott, Emma S Long, Georgina V Guminski, Alexander Clifton-Bligh, Roderick J Menzies, Alexander M Tsang, Venessa H Producer: 20180110 In: European journal of endocrinology vol. 178 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1846.	The immunocytokine L19-IL2 eradicates cancer when used in combination with CTLA-4 blockade or with L19-TNF. [electronic resource] by Schwager, Kathrin Hemmerle, Teresa Aebischer, David Neri, Dario Producer: 20130620 In: The Journal of investigative dermatology vol. 133 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1847.	Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. [electronic resource] by Weber, Jeffrey S D'Angelo, Sandra P Minor, David Hodi, F Stephen Gutzmer, Ralf Neyns, Bart Hoeller, Christoph Khushalani, Nikhil I Miller, Wilson H Lao, Christopher D Linette, Gerald P Thomas, Luc Lorigan, Paul Grossmann, Kenneth F Hassel, Jessica C Maio, Michele Sznol, Mario Ascierto, Paolo A Mohr, Peter Chmielowski, Bartosz Bryce, Alan Svane, Inge M Grob, Jean-Jacques Krackhardt, Angela M Horak, Christine Lambert, Alexandre Yang, Arvin S Larkin, James Producer: 20150629 In: The Lancet. Oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1848.	Bevacizumab plus ipilimumab in patients with metastatic melanoma. [electronic resource] by Hodi, F Stephen Lawrence, Donald Lezcano, Cecilia Wu, Xinqi Zhou, Jun Sasada, Tetsuro Zeng, Wanyong Giobbie-Hurder, Anita Atkins, Michael B Ibrahim, Nageatte Friedlander, Philip Flaherty, Keith T Murphy, George F Rodig, Scott Velazquez, Elsa F Mihm, Martin C Russell, Sara DiPiro, Pamela J Yap, Jeffrey T Ramaiya, Nikhil Van den Abbeele, Annick D Gargano, Maria McDermott, David Producer: 20150723 In: Cancer immunology research vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1849.	Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report. [electronic resource] by Kwatra, Vineet Karanth, Narayan V Priyadarshana, Kelum Charakidis, Michail Producer: 20170907 In: Journal of medical case reports vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1850.	Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma. [electronic resource] by Shoushtari, Alexander N Friedman, Claire F Navid-Azarbaijani, Pedram Postow, Michael A Callahan, Margaret K Momtaz, Parisa Panageas, Katherine S Wolchok, Jedd D Chapman, Paul B Producer: 20190906 In: JAMA oncology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1851.	Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity. [electronic resource] by Minniti, Giuseppe Anzellini, Dimitri Reverberi, Chiara Cappellini, Gian Carlo Antonini Marchetti, Luca Bianciardi, Federico Bozzao, Alessandro Osti, Mattia Gentile, Pier Carlo Esposito, Vincenzo Producer: 20200707 In: Journal for immunotherapy of cancer vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1852.	Oncolytic virotherapy, alone or in combination with immune checkpoint inhibitors, for advanced melanoma: A systematic review and meta-analysis. [electronic resource] by Zou, Puyu Tang, Rui Luo, Mei Producer: 20200713 In: International immunopharmacology vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1853.	How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma. [electronic resource] by Li, Meng Basu, Anirban Bennette, Caroline Veenstra, David Garrison, Louis P Producer: 20191209 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1854.	CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma. [electronic resource] by Prieto, Peter A Yang, James C Sherry, Richard M Hughes, Marybeth S Kammula, Udai S White, Donald E Levy, Catherine L Rosenberg, Steven A Phan, Giao Q Producer: 20120823 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1855.	Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma. [electronic resource] by Yamazaki, N Kiyohara, Y Uhara, H Fukushima, S Uchi, H Shibagaki, N Tsutsumida, A Yoshikawa, S Okuyama, R Ito, Y Tokudome, T Producer: 20160128 In: Cancer chemotherapy and pharmacology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1856.	Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors´ treatment: Spectrum of imaging appearances. [electronic resource] by Malikova, Hana Holesta, Michal Fialova, Alena Arenbergerova, Monika Weichet, Jiri Producer: 20190312 In: Neuro endocrinology letters vol. 39 Availability: No items available. Save to lists Add to cart (remove)
	1857.	Sequential treatment approaches in the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysis. [electronic resource] by Tarhini, Ahmad Benedict, Agnes McDermott, David Rao, Sumati Ambavane, Apoorva Gupte-Singh, Komal Sabater, Javier Ritchings, Corey Aponte-Ribero, Valerie Regan, Meredith M Atkins, Michael Producer: 20190827 In: Immunotherapy vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1858.	T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. [electronic resource] by Hopkins, Alexander C Yarchoan, Mark Durham, Jennifer N Yusko, Erik C Rytlewski, Julie A Robins, Harlan S Laheru, Daniel A Le, Dung T Lutz, Eric R Jaffee, Elizabeth M Producer: 20191104 In: JCI insight vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1859.	Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials. [electronic resource] by Verma, Vivek Cushman, Taylor R Selek, Ugur Tang, Chad Welsh, James W Producer: 20190509 In: International journal of radiation oncology, biology, physics vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1860.	PROSTVAC® targeted immunotherapy candidate for prostate cancer. [electronic resource] by Shore, Neal D Producer: 20150129 In: Immunotherapy vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 2033 results.